J0665Drugs Administered Other than Oral Method

Injection, bupivicaine, not otherwise specified, 0.5 mg

Short description: Inj, bupivacaine, nos, 0.5mg

Effective date: January 1, 2024
Termination date: —

Related codes (J-series)

J0013Esketamine, nasal spray J0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius J0135Adalimumab injection

Frequently asked questions

What is HCPCS code J0665?

J0665 is a HCPCS Level II code for Injection, bupivicaine, not otherwise specified, 0.5 mg.

What category is HCPCS code J0665 in?

J0665 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.

When did HCPCS code J0665 become effective?

J0665 has been effective since January 1, 2024, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.